Evidence map›Paper›PMID 40589267›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2025

Evidence-Based Lung Cancer Screening in a Tailored Package.

Abbie Begnaud, Frank G Ondrey

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Abbie BegnaudPulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Lung Cancer Screening Program, University of Minnesota Health, Minneapolis, Minnesota.ORCID 0000-0001-5634-1638
Frank G OndreyDepartment of Otolaryngology, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-4951-9335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer screening practices are amalgamated into the entire spectrum of cancer prevention efforts that range from primary prevention (e.g., avoiding tobacco and limiting sun exposure) to screening measures after risk assessment (mammography, colonoscopy, pap smears, etc.) and tertiary measures (e.g., lesion ablation after identification and cancer follow-up examinations for secondary primaries). Marginalized groups often have difficulty gaining access to screening, and improving screening rates is challenging. The Tribally Engaged Approaches to Lung Screening (TEALS) study for lung cancer screening in the American Indian/Alaska Native population in Oklahoma represents a comprehensive effort that has significantly improved lung cancer screening for high-risk individuals on the Choctaw Nation. See related article by Nagykaldi et al., p. 423.

Indexed as

Early Detection of CancerEvidence-Based MedicineLung NeoplasmsMass ScreeningFemaleHumansMale

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.